Knowledge Centre

Annual Letter From The CEO

Dear Stakeholders, As we step into 2025, I’d like to take a moment to reflect on the remarkable progress we’ve made in the CRISPR landscape…

A Letter from the CEO

  ERS Genomics stands as the global leader in CRISPR/Cas9 licensing, uniquely positioned at the intersection of cutting-edge science, commercial accessibility, and responsible innovation. Our…

Prime Editing

CRISPR/Cas9 Prime Editing is a novel gene editing technique that utilizes a modified Cas9 protein to introduce mutations in the genome with a higher degree…

CRISPR and More Delicious

  The United Nations predicts that there will be an additional 2.2 billion people on the planet by 2050. To help feed the growing population,…

CRISPR-Cas9 Bioremediation

A new era for environmental recovery Population growth and industrialisation has led to harmful pollution of our air, freshwater, oceans, and soil. Water quality has worsened…

Unlocking the power of Prokaryotes

CRISPR/Cas9 technology has emerged as a revolutionary tool in the field of genetics and biotechnology, allowing for precise and targeted editing of the genome of…